Literature DB >> 21270784

From reinforcement learning models to psychiatric and neurological disorders.

Tiago V Maia1, Michael J Frank.   

Abstract

Over the last decade and a half, reinforcement learning models have fostered an increasingly sophisticated understanding of the functions of dopamine and cortico-basal ganglia-thalamo-cortical (CBGTC) circuits. More recently, these models, and the insights that they afford, have started to be used to understand important aspects of several psychiatric and neurological disorders that involve disturbances of the dopaminergic system and CBGTC circuits. We review this approach and its existing and potential applications to Parkinson's disease, Tourette's syndrome, attention-deficit/hyperactivity disorder, addiction, schizophrenia and preclinical animal models used to screen new antipsychotic drugs. The approach's proven explanatory and predictive power bodes well for the continued growth of computational psychiatry and computational neurology.

Entities:  

Mesh:

Year:  2011        PMID: 21270784      PMCID: PMC4408000          DOI: 10.1038/nn.2723

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  129 in total

Review 1.  Opponent interactions between serotonin and dopamine.

Authors:  Nathaniel D Daw; Sham Kakade; Peter Dayan
Journal:  Neural Netw       Date:  2002 Jun-Jul

2.  Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.

Authors:  Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer
Journal:  Nature       Date:  2010-07-07       Impact factor: 49.962

3.  Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior.

Authors:  Takatoshi Hikida; Kensuke Kimura; Norio Wada; Kazuo Funabiki; Shigetada Nakanishi
Journal:  Neuron       Date:  2010-06-24       Impact factor: 17.173

4.  Addiction as a computational process gone awry.

Authors:  A David Redish
Journal:  Science       Date:  2004-12-10       Impact factor: 47.728

Review 5.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

6.  Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.

Authors:  Stefano Palminteri; Maël Lebreton; Yulia Worbe; David Grabli; Andreas Hartmann; Mathias Pessiglione
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

Review 7.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

8.  Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study.

Authors:  S Bohlhalter; A Goldfine; S Matteson; G Garraux; T Hanakawa; K Kansaku; R Wurzman; M Hallett
Journal:  Brain       Date:  2006-03-06       Impact factor: 13.501

Review 9.  A unified framework for addiction: vulnerabilities in the decision process.

Authors:  A David Redish; Steve Jensen; Adam Johnson
Journal:  Behav Brain Sci       Date:  2008-08       Impact factor: 21.357

Review 10.  Dopamine signals for reward value and risk: basic and recent data.

Authors:  Wolfram Schultz
Journal:  Behav Brain Funct       Date:  2010-04-23       Impact factor: 3.759

View more
  222 in total

1.  PET evidence for a role for striatal dopamine in the attentional blink: functional implications.

Authors:  Heleen A Slagter; Rachel Tomer; Bradley T Christian; Andrew S Fox; Lorenza S Colzato; Carlye R King; Dhanabalan Murali; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2012-06-04       Impact factor: 3.225

2.  Changes in corticostriatal connectivity during reinforcement learning in humans.

Authors:  Guillermo Horga; Tiago V Maia; Rachel Marsh; Xuejun Hao; Dongrong Xu; Yunsuo Duan; Gregory Z Tau; Barbara Graniello; Zhishun Wang; Alayar Kangarlu; Diana Martinez; Mark G Packard; Bradley S Peterson
Journal:  Hum Brain Mapp       Date:  2014-11-12       Impact factor: 5.038

3.  Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions.

Authors:  Pierre F Durieux; Serge N Schiffmann; Alban de Kerchove d'Exaerde
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

4.  The scylla and charybdis of neuroeconomic approaches to psychopathology.

Authors:  P Read Montague
Journal:  Biol Psychiatry       Date:  2012-07-15       Impact factor: 13.382

5.  Test-retest reliability of effective connectivity in the face perception network.

Authors:  Stefan Frässle; Frieder Michel Paulus; Sören Krach; Andreas Jansen
Journal:  Hum Brain Mapp       Date:  2015-11-27       Impact factor: 5.038

Review 6.  The molecular and cellular mechanisms of depression: a focus on reward circuitry.

Authors:  Megan E Fox; Mary Kay Lobo
Journal:  Mol Psychiatry       Date:  2019-04-09       Impact factor: 15.992

7.  Associability-modulated loss learning is increased in posttraumatic stress disorder.

Authors:  Vanessa M Brown; Lusha Zhu; John M Wang; B Christopher Frueh; Brooks King-Casas; Pearl H Chiu
Journal:  Elife       Date:  2018-01-09       Impact factor: 8.140

8.  Identifying cognitive remediation change through computational modelling--effects on reinforcement learning in schizophrenia.

Authors:  Matteo Cella; Anthony J Bishara; Evelina Medin; Sarah Swan; Clare Reeder; Til Wykes
Journal:  Schizophr Bull       Date:  2013-11-09       Impact factor: 9.306

9.  The drift diffusion model as the choice rule in reinforcement learning.

Authors:  Mads Lund Pedersen; Michael J Frank; Guido Biele
Journal:  Psychon Bull Rev       Date:  2017-08

Review 10.  Cognitive Neuroscience of Eating Disorders.

Authors:  Joanna E Steinglass; Laura A Berner; Evelyn Attia
Journal:  Psychiatr Clin North Am       Date:  2018-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.